TB–IRIS occurs frequently in persons with advanced HIV infection and in those presenting with extra-pulmonary TB...
03 Jul 2020
Sex and obesity are independently associated with residual viremia in people on long-term ART. Additional studies to...
02 Jul 2020
Most cases had hypervitaminosis A and altered antioxidant capacities that could affect immunological response. Wide-...
01 Jul 2020
In our chronic PLWH on virological suppression for 4 years, the prevalence of HIV-DNA < 100 copies/106 PBMCs was...
26 Jun 2020
This is a 48-week subgroup analysis of evaluating the efficacy and safety of FTC/ TAF by the class of coadministered third agent (boosted PI vs...
The ADVANCE trial compared the efficacy and safety of a triple-therapy combination of emtricitabine and dolutegravir (DTG) plus either of two...
This was a 144-week analysis comparing the efficacy and safety of TAF vs TDF, each co-formulated with elvitegravir, cobicistat, and emtricitabine (e...
This trial compares the safety and efficacy of TAF vs TDF co-formulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of...
Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...
Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...
This publication features commonly asked questions by HIV patients regarding HIV therapy, drug side-effects, Do’s and Don’ts while on HIV treatment....
This publication features common questions which arise in HIV patients mind regarding HIV, diagnosis, transmission, treatment and drug side effects. ...
This slide set covers the epidemiology, disease progression and management of HIV-HCV coinfection in the era of directly acting antivirals available...
PrEP is the use of an antiretroviral medication by HIV-negative individuals to prevent them from acquiring HIV. These slides give an overview on the...
Post-exposure prophylaxis (PEP) is the method of preventing exposures of HIV to blood and body fluids and it is considered to be the most important...
HIV is the strongest risk factor for developing tuberculosis (TB) disease in those with latent or new Mycobacterium tuberculosis infection....